Global X Genomics & Biotechnology ETF
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Total operating expenses were $60,330,000.
Profit Margin
| 2011 | 19.34M | -72.34M | -374.01% |
|---|
GNOM Income Statement (2011 – 2011)
| 2011 | |
|---|---|
Revenue | |
Revenue | 19.34M |
Cost of revenue | 28.30M |
Gross profit | -8.96M |
Operating exp. | |
Research and development | 32.69M |
Selling and marketing | 13.6M |
Total operating expenses | 60.33M |
Operating income | -69.29M |
Other income (expenses), net | 3.05M |
Income before tax | -72.34M |
Income tax expense | 0 |
Net income | -72.34M |
Earnings per share | |
Basic EPS | -2.12 |
Diluted EPS | -2.14 |
| Data source |